Glucose-activated p300 acetylated Lys-672 of the carbohydrate-responsive element-binding protein (ChREBP) and increased its transcriptional activity, leading to increased hepatic lipogenesis and the development of NAFLD [88,103]. The gene discussed is EP300; the disease is metabolic dysfunction-associated steatotic liver disease.